Albany, NY -- (SBWire) -- 07/17/2018 --This report studies the global G-CSF Biosimilars market status and forecast, categorizes the global G-CSF Biosimilars market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.
Granulocyte colony-stimulating factor (G-CSF) is a glycoprotein containing 174 amino acids with a molecular weight of about 20000.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for G-CSF Biosimilars in US$ by the following Product Segments: Human growth hormone, Erythropoietin, Monoclonal antibodies, Insulin, Interferon, Granulocyte-Colony Stimulating Factor
Click to get Sample PDF: https://www.researchmoz.us/enquiry.php?type=S&repid=1858015
Company profiles are primarily based on public domain information including company
- Merck & Co.
- Sanofi
- Johnson & Johnson
- Gilead Science
- GlaxoSmithKline
- AbbVie
- Amgen
- AstraZeneca
- Bayer
- Pfizer
- Novartis
- Roche
The major manufacturers covered in this report
- Pfizer
- Novartis
- Roche
- Merck & Co.
- Sanofi
- Johnson & Johnson
- Gilead Science
- GlaxoSmithKline
- AbbVie
- Amgen
- AstraZeneca
- Bayer
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
- Human Growth Hormone
- Erythropoietin
- Monoclonal Antibodies
- Insulin
- Interferon
- Granulocyte-Colony Stimulating Factor
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
- Blood Disorders
- Oncology Diseases
- Chronic And Autoimmune Diseases
- Growth Hormone Deficiencies
View Complete TOC with Tables and Figures at: https://www.researchmoz.us/global-g-csf-biosimilars-market-research-report-2018-report.html/toc
Key Stakeholders
- G-CSF Biosimilars Manufacturers
- G-CSF Biosimilars Distributors/Traders/Wholesalers
- G-CSF Biosimilars Subcomponent Manufacturers
- Industry Association
- Downstream Vendors
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket
Albany NY - 12207
United States
Tel: +1-518-621-2074
Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Global G-CSF Biosimilars Market Forecast 2018-2025: Merck & Co., Sanofi, Johnson & Johnson, Gilead Science, GlaxoSmithKline